Computational Analysis of Deleterious SNPs in NRAS to Assess Their Potential Correlation With Carcinogenesis

Mohammed Y Behairy1, Mohamed A Soltan2, Mohamed S Adam3

  • 1Department of Microbiology and Immunology, Faculty of Pharmacy, University of Sadat City, Sadat City, Egypt.

Frontiers in Genetics
|September 2, 2022
PubMed

Insights

Identifying deleterious NRAS gene mutations is crucial for understanding cancer. This study found 14 single nucleotide polymorphisms (SNPs) that increase cancer risk, with five showing the highest potential. Further research is recommended.

Area of Science:

  • Genetics
  • Molecular Biology
  • Oncology

Background:

  • The NRAS gene is a key oncogene implicated in various human cancers.
  • Mutations in NRAS are frequently observed in tumor pathogenesis.
  • Identifying specific deleterious mutations is vital for targeted cancer therapy.

Purpose of the Study:

  • To identify and comprehensively analyze deleterious missense single nucleotide polymorphisms (SNPs) in the NRAS gene.
  • To determine the impact of these SNPs on NRAS protein stability, function, and carcinogenic potential.
  • To investigate the structural and functional consequences of high-risk NRAS mutations.

Main Methods:

  • In silico analysis of NRAS missense SNPs using six prediction tools.
  • Structural biology methods and molecular docking to assess SNP behavior and GTP binding affinity.
  • Molecular dynamics simulations to evaluate the thermodynamic stability of SNP models.

Main Results:

  • 17 deleterious NRAS mutations were identified, with 14 predicted to increase carcinogenesis risk.
  • Most identified SNPs decreased NRAS protein stability and were located in conserved functional domains.
  • 14 mutations showed increased binding affinity to GTP, suggesting enhanced malignancy.
  • Five mutations (G13R, G13C, G13V, P34R, V152F) were associated with the highest cancer risk.
  • Molecular dynamics simulations confirmed stability and altered GTP binding for high-risk SNP models.

Conclusions:

  • The study identified 14 high-risk NRAS SNPs with significant implications for carcinogenesis.
  • These mutations potentially enhance NRAS activity through altered GTP binding and stability.
  • Experimental validation of these findings could provide new therapeutic targets for NRAS-driven tumors.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.9K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.7K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K